Market icon
科技·特朗普

TrumpRX launched by January 31, 2026?

Market icon
科技·特朗普

TrumpRX launched by January 31, 2026?

Ended: 1月 31

Ended: 1月 31

<1% 機率
Polymarket

$303,218 交易量

<1% 機率
Polymarket

$303,218 交易量

TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels. This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No." To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public. Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access. This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable. The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.

This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."

To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.

Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.

This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.

The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
交易量
$303,218
結束日期
2026-01-31
市場開放時間
Nov 13, 2025, 5:50 PM ET

Resolver

0x65070BE91...
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels. This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No." To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public. Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access. This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable. The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

已提議結果: No

無爭議

最終結果: No

TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels. This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No." To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public. Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access. This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable. The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels.

This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No."

To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public.

Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access.

This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable.

The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.
交易量
$303,218
結束日期
2026-01-31
市場開放時間
Nov 13, 2025, 5:50 PM ET

Resolver

0x65070BE91...
TrumpRx (https://trumprx.gov/) is scheduled to launch in January 2026 and is intended to help consumers access lower-cost medications by directing them to manufacturers’ direct-to-consumer purchasing channels. This market will resolve to "Yes" if TrumpRx.gov becomes publicly accessible in a form that allows members of the public to search for and find medications by January 31, 2026, 11:59 PM ET. Otherwise, this market will resolve to "No." To qualify, the site must be publicly accessible and operational in at least a limited capacity, meaning it functions in its intended portal role by allowing users to search for or view medications and be redirected to purchase them. Glitches or minor technical issues will not render the site non-functional, provided the core portal functionality remains available to the public. Once the qualifying functionality goes live, the market will resolve to "Yes" immediately, regardless of any subsequent reversal, rollback, or withdrawal of access. This market will resolve to "No" if TrumpRx.gov becomes permanently unavailable. The primary resolution source for this market will be TrumpRx.gov; however, a consensus of credible reporting will also be used.

已提議結果: No

無爭議

最終結果: No

警惕外部連結哦。

Frequently Asked Questions

"TrumpRX launched by January 31, 2026?" is a prediction market on Polymarket where traders buy and sell "Yes" or "No" shares based on whether they believe this event will happen. The current crowd-sourced probability is 0% for "Yes." For example, if "Yes" is priced at 0¢, the market collectively assigns a 0% chance that this event will occur. These odds shift continuously as traders react to new developments and information. Shares in the correct outcome are redeemable for $1 each upon market resolution.

As of today, "TrumpRX launched by January 31, 2026?" has generated $303.2K in total trading volume since the market launched on Nov 13, 2025. This level of trading activity reflects strong engagement from the Polymarket community and helps ensure that the current odds are informed by a deep pool of market participants. You can track live price movements and trade on any outcome directly on this page.

To trade on "TrumpRX launched by January 31, 2026?," simply choose whether you believe the answer is "Yes" or "No." Each side has a current price that reflects the market's implied probability. Enter your amount and click "Trade." If you buy "Yes" shares and the outcome resolves as "Yes," each share pays out $1. If it resolves as "No," your "Yes" shares pay $0. You can also sell your shares at any time before resolution if you want to lock in a profit or cut a loss.

The current probability for "TrumpRX launched by January 31, 2026?" is 0% for "Yes." This means the Polymarket crowd currently believes there is a 0% chance that this event will occur. These odds update in real-time based on actual trades, providing a continuously updated signal of what the market expects to happen.

The resolution rules for "TrumpRX launched by January 31, 2026?" define exactly what needs to happen for each outcome to be declared a winner — including the official data sources used to determine the result. You can review the complete resolution criteria in the "Rules" section on this page above the comments. We recommend reading the rules carefully before trading, as they specify the precise conditions, edge cases, and sources that govern how this market is settled.